September 12, 2013 - The court ordered the authorization of the distribution of the net settlement fund.
June 4, 2012 - The court approved the settlement, entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissed the action with prejudice.

February 10, 2012 - The court preliminarily approved the settlement.

February 9, 2012 - Parties filed a stipulation of settlement.

July 20, 2010 - The court denied in part and granted in part the defendants' motion to dismiss.

February 16, 2010 - The defendants filed a motion to dismiss.

December 18, 2009 - The lead plaintiff filed a second amended consolidated complaint on behalf of investors who purchased ARTC common shares between May 10, 2005 and February 18, 2009. The lead plaintiff alleges that the defendants violated the Securities Exchange Act of 1934 by issuing false and misleading statements between May 10, 2005 and February 18, 2009.

June 12, 2009 - The court ordered another case to be consolidated.

December 10, 2008 - The court appointed a new lead plaintiff and lead counsel.

November 25, 2008 - The court ordered another case to be consolidated.

October 25, 2008 - The court ordered two cases to be consolidated.

October 28, 2008 - The court granted the defendants motion to change venue transferring the case to the U.S. District Court for the Western District of Texas.

October 17, 2008 - The lead plaintiff filed an amended complaint on behalf of investors who purchased ARTC common shares between May 3, 2006 and July 18, 2008. The lead plaintiff alleges that the defendants violated the Securities Exchange Act of 1934 by issuing false and misleading statements between May 3, 2006 and July 18, 2008.

September 10, 2008 - The defendants filed a motion to change venue.

July 25, 2008 - Another investor filed a complaint.

July 16, 2008 - The lead plaintiff and lead counsel were appointed. The court denied the plaintiff's motion to consolidate.

June 4, 2008 - The court granted the plaintiff's motion to stay and denied the defendant's motion to dismiss as moot.

June 3, 2008 - Lead plaintiff motions were filed.

April 11, 2008 - The plaintiff filed a motion to stay.

April 7, 2008 - The defendants filed a motion to dismiss.

April 4, 2008 - An investor in shares of ArthroCare Corporation (NASDAQ: ARTC) filed a lawsuit in the U.S. District Court for the Southern District of Florida against ArthroCare Corporation over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between August 4, 2006 and January 23, 2008.

The complaint charges ArthroCare Corporation and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Specifically, the complaint alleges that between August 4,2006 and January 23, 2008, defendants issued materially false and misleading statements and failed to disclose the following adverse facts which were known to defendants or recklessly disregarded by them: that ArthroCare Corporation’s reported financial results were materially overstated due to the improper inclusion and recognition of revenue attributable to purported “purchases” of medical devices by DiscoCare Inc (“DiscoCare”), an ArthroCare Corporation “sales agent” for the sale of ArthroCare Corporation medical devices. More specifically, defendants violated Generally Accepted Accounting Practices (”GAAP”) in numerous material respects by, inter alia,: (i) recognizing revenue where payment for the shipment of ArthroCare Corporation’s products was not unconditional, but was entirely contingent upon the decision of third-party payers to pay for the ArthroCare Corporation device or the successful resolution of personal injury lawsuits; (ii) recognizing revenue from transactions with DiscoCare Inc where DiscoCare Inc did not have an unconditional obligation to pay ArthroCare Corporation for certain products; (iii) recognizing revenue from bill and hold transactions between the Company and DiscoCare Inc involving certain products which were to be paid for pursuant to the contingent payment arrangement; and (iv) materially overstating financial results due to the improper inclusion and recognition of revenue attributable to purported “purchases” of medical devices by a related party, Device Reimbursement Services (“DRS”).

According to the complaint between August 4, 2006 and January 23, 2008, ArthroCare Corporation's (NASDAQ: ARTC) stock price rose, reaching a high of $64.84 on October 31, 2007. As a result of a series of adverse news stories and partial disclosures concerning the propriety of ArthroCare Corporation's business relationship with DiscoCare Inc and DRS, as well as the accuracy of ArthroCare Corporation's reported financial results, culminating with an article dated January 23, 2008, the price of ArthroCare Corporation's (NASDAQ: ARTC) stock decreased to approximately $38.11 by January 25, 2008.

ArthroCare Corporation designs, develops, manufactures, and markets medical devices for use in soft-tissue surgery. Its products are based on the patented soft-tissue surgical controlled ablation technology called Coblation technology.